Registry of Lobbyists
Total Number of Communication Reports: 24
Monthly communication reports in the last 6 months: 0
Version 1 of 11 (2006-06-15 to 2007-01-04) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Schering Plough Canada Inc.
3535 Trans-Canada Highway Pointe-Claire, QC H9R 1B4 Canada |
| Telephone number: | 514-426-7300 |
| Fax number: | |
| Responsible officer name and position during the period of this registration: | Carlos Dourado, President and General Manager |
| Description of activities: | Schering Canada provides Canadians with innovative and effective medicines. We are committed to maintaining and improving the health of Canadians to ensure their quality of life. Through science and investment in research and development we work to respond to the needs of healthcare providers, patients and other customers quickly and effectively. |
| The client is a subsidiary of the following parent companies: |
Schering-Plough
2000 Galloping Hill Road Kenilworth, NJ United States of America 07033-0530 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Roy Anthony Hebden |
| Position title: | National Director, Government and Health Affairs |
| Public offices held: | No |
| Name: | Nikki Macdonald |
| Position title: | Manager, Federal Health Affairs |
| Public offices held: | Yes |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Citizenship and Immigration Canada, Competition Tribunal (CT), Correctional Service of Canada (CSC), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Procurement Review Board of Canada (PRB), Public Service Commission of Canada (PSC), Royal Canadian Mounted Police (RCMP), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC) | ||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||
| Subject Matter: Areas of Concern: | Aboriginal Affairs, Consumer Issues, Defence, Education, Employment and Training, Government Procurement, Health, Immigration, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance | ||||||||
| Subject Matter: Retrospective: | Product Listing for Reimbursement on Federal Plans, The Food and Drug Act, Clinical Trial Regulations, Health Canada Pharmaceutical Policies, The Drug Product Review and Approval Process | ||||||||
| Subject Matter: Prospective: | Product Listing for Reimbursement on Federal Plans, The Food and Drug Act, Innovation and Commercialization Strategy, Research and Development, Technology and Research, Federal/Provincial/Territorial Institutions and Issues related to Pharmaceuticals, Canadian Institutes of Health Research, Health Canada Pharmaceutical Strategy, Common Drug Review Process, Access to Medicines, International and inter-provincial issues of trade and access, Canada-US Relations, Competition Act, Patents and Regulatory Reform | ||||||||
Details Regarding the Identified Subject Matter
|
|||||||||